3Grundy SM. Cholesterol and coronary heart disease. The 21st century[J]. Arch Intern Med, 1997,157 : 1177 - 1184.
4Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Aduhs.Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults ( Adult Treatment Panel Ⅱ )[J] .JAMA, 1993,269:3015- 3023.
5Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart desease : the Scandinavian Simvastatin Survival Study (4S) [J].Lacent, 1994,344: 1383 - 1389.
6Sacks FM,Pfeffer MA, Moye LA et al. The effect of pravastatin on coronarv events after myocardial infarction in patients with average cholesterol levels[J] . N Engl J Med, 1996,335 : 1001 -1009.
7The Long-Term Intervention with Pravastatin in Ischaemia Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J] . N Engl J Med,1998,339: 1349 - 1357.
8Pitt B, Waters D, Brown WV et al. Aggressive lipid-lowerlng therapy compared with angioplasty in stable coronary artery disease[J] .N Engl J Med, 1999,341:70- 76.
9MAAS investigators. Effect of simvastatin on coronary atheroma:the Multicentre Anti-Atheroma Study (MAAS) [J]. Lacent,1994,344:633 - 863.
10Jukema JW, Bruschke AVG, van Boven AJ et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Studv(REGRESS) [J]. Circulation, 1995,91 : 2528- 2540.
